"We felt it could have been a huge cost and a huge policy discussion," one GOP senator said of the move.

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

According to the Gallup National Health and Well-Being Index, 37% of U.S. adults now report obesity, down from 39.9% three ...

Medically reviewed by Erika Prouty, PharmD Key Takeaways GLP-1 medications already slow digestion and can cause stomach upset. If adding magnesium, start with a low dose and increase gradually to ...

Understood reports GLP-1 drugs like Ozempic may improve ADHD symptoms by quieting food thoughts, but more research is needed for direct effects.

The evolving story of GLP-1 receptor agonists in oncology has yet another new chapter.Several studies presented at San Antonio Breast Cancer Symposium suggested the medications may help extend ...

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.

Increasingly popular GLP-1 drugs used to treat diabetes and obesity show promise in fighting multiple substance use disorders ...

In studies published so far, GLP-1 receptor agonists appear to be beneficial for the treatment of glaucoma, according to a review published in Cureus.“GLP-1 RAs exert both protective and adverse ...

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ ...